0001610717-24-000232.txt : 20240507 0001610717-24-000232.hdr.sgml : 20240507 20240507170634 ACCESSION NUMBER: 0001610717-24-000232 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240506 FILED AS OF DATE: 20240507 DATE AS OF CHANGE: 20240507 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jones William Benton CENTRAL INDEX KEY: 0001664506 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37719 FILM NUMBER: 24923090 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD, SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corvus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001626971 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 464670809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: (650) 900-4520 MAIL ADDRESS: STREET 1: 863 MITTEN ROAD STREET 2: SUITE 102 CITY: BURLINGAME STATE: CA ZIP: 94010 4 1 form4.xml X0508 4 2024-05-06 0001626971 Corvus Pharmaceuticals, Inc. CRVS 0001664506 Jones William Benton C/O CORVUS PHARMACEUTICALS, INC. 863 MITTEN ROAD, SUITE 102 BURLINGAME CA 94010 true See Remarks false Common Stock 2024-05-06 4 P 0 20000 1.7312 A 153773 D Warrant (Right to Buy) 3.5 2024-05-06 4 P 0 19357 A 2024-05-06 2025-06-30 Common Stock 19357 19357 D Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312. SVP, Pharmaceutical Development /s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D. 2024-05-07